PMID: 6106389Oct 1, 1980Paper

Tardive dyskinesia: summary of a Task Force Report of the American Psychiatric Association. By the Task Force on Late Neurological Effects of Antipsychotic Drugs

The American Journal of Psychiatry

Abstract

Abnormal movements associated with the prolonged use of antipsychotic drugs (tardive dyskinesia) occur in at least 10%-20% of the patients at risk; prevalence is higher among the elderly. The casue is unknown, but increased sensitivity to dopamine in the basal ganglia may contribute to the pathophysiology. Many treatments have been evaluated; none is satisfactory. While the problem is serious, an alarmist view is unwarranted, especially since many cases are detected early and improve spontaneously. The best approach currently is to use antipsychotic drugs thoughtfully for clear indications, the best supported of which, scientifically, is chronic schizophrenia. There is a search for new agents with much less adverse neurologic effect but with adequate antipsychotic efficacy. This article summarizes an APA Task Force Report.

Citations

Jan 1, 1984·Psychopharmacology·R J Carey, J DeVeaugh-Geiss
Nov 30, 2014·Neurologic Clinics·Shyamal H MehtaKapil D Sethi
Feb 1, 1990·Journal of Neuroimmunology·W S MetzerS Hays
Oct 6, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·D Naber, A Karow
Oct 6, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·J M Kane
Dec 1, 1991·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·H LublinE Tolvanen
Jan 16, 1998·European Journal of Pharmacology·A N SussmanJ L Neisewander
Apr 1, 1992·Acta Psychiatrica Scandinavica·M LejoyeuxP Gorwood
Feb 22, 1985·Pharmaceutisch Weekblad. Scientific Edition·A J Loonen, W Soudijn
Apr 1, 1983·Psychiatry Research·S KorsgaardJ Gerlach
Dec 1, 1985·Psychiatry Research·J T WegnerJ Lieberman
Jan 15, 1988·Biological Psychiatry·J E SorokinK L Davis
Jan 1, 1984·Journal of Neurology·J ZeitlhoferT Reisner
Jan 1, 1981·Progress in Neuro-psychopharmacology·C A NaranjoE M Sellers
Jan 1, 1981·Progress in Neuro-psychopharmacology·D RadonjicV Knott
Dec 1, 1982·Biofeedback and Self-regulation·J D Frank
Jan 1, 1983·Psychopharmacology·B WistedtA Jørgensen
Jan 1, 1983·Psychopharmacology·N BjørndalE Christensson
Jan 1, 1983·Psychopharmacology·J Hajioff, M Wallace
Jan 1, 1984·Psychopharmacology·S KorsgaardJ Gerlach
Jan 1, 1982·Psychopharmacology·D V JesteR J Wyatt
Jan 1, 1982·Psychopharmacology·D E CaseyN Bjørndal
Jan 1, 1984·Psychopharmacology·B Kovacic, E F Domino
Nov 30, 2000·Current Treatment Options in Neurology·D Tarsy
Feb 1, 1990·Pharmacology, Biochemistry, and Behavior·P M CarveyH L Klawans
Sep 1, 1989·Pharmacology, Biochemistry, and Behavior·G T Barthalmus
Jul 1, 1994·Journal of Mental Health Administration·K G TerkelsenB E Hurley
Sep 10, 2003·Neuropsychology·Barbara L SchwartzStephen I Deutsch
Aug 1, 1983·Brain Research Bulletin·C Y Yung
Sep 1, 1990·Journal of American College Health : J of ACH·B P Karon
Jul 1, 1987·The International Journal of Neuroscience·R Sandyk
Sep 24, 2015·The International Journal of Neuroscience·Zhiyu LvZuoxiao Li
Jan 23, 2016·Neurology·Hélène Pouclet-CourtemanchePhilippe Damier
May 1, 1982·Psychosomatics·M E WolfA D Mosnaim
Sep 18, 1998·Electrophoresis·N L Anderson, N G Anderson
Jan 1, 1994·Chest·P G WilcoxJ A Fleetham
Aug 1, 1989·Applied Nursing Research : ANR·A L WhallL A Weissfeld
Apr 1, 1986·Journal of the American Academy of Dermatology·M A GuptaH F Haberman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annual Review of Medicine
D Tarsy, R J Baldessarini
Clinics in Geriatric Medicine
Kelvin L Chou, Joseph H Friedman
JAMA : the Journal of the American Medical Association
Bruce L SaltzK Kahaner
Journal of the American Medical Directors Association
Richard J Goldberg
Journal of the American Medical Directors Association
Richard J Goldberg
© 2021 Meta ULC. All rights reserved